The Questions a Bad Program Hopes You Skip
SaveA good program is not annoyed by hard questions; it is relieved by them, because the honest answers are its strongest sales pitch. A bad program does the opposite. It redirects, reassures, and hurries you toward a deposit before you can ask the things that would give it away. This page lists the specific questions that separate the two, and what a dodge on each one is really telling you.
Last updated: July 2026
What questions does a bad rehab avoid?
A bad rehab avoids any question with a verifiable answer, because verification is exactly what it cannot survive. The questions that matter are not about comfort or philosophy; they are about license, accreditation, how care is matched to you, whether real medications are offered, how success is measured, what it all costs, and who profits from your admission. The reaction to a question is often more informative than the answer: a good program welcomes scrutiny, and a predatory one treats it as an obstacle.
What follows is a short set of questions to ask a rehab, each paired with the honest answer a good program gives and the dodge a bad one offers instead. You do not need to be an expert to use them. The skill is not in evaluating a clinical answer but in noticing whether you get a clear, checkable one at all. A program that answers plainly and points you to where you can confirm it has told you most of what you need to know.
Who licenses and accredits you, and when were you last reviewed?
This is the first question a bad program hopes you skip, because license and accreditation are verifiable and evasion is itself the answer. A good program names its state license and its accrediting body without hesitation. Accreditation by The Joint Commission, for example, means an outside reviewer inspected the facility against national safety and quality standards, with on-site reviews conducted at least every three years 1Ref 1The Joint Commission (2024).Behavioral Health Care and Human Services Accreditation Program.That accreditation by The Joint Commission means an outside reviewer inspected the facility against national safety and quality standards with on-site reviews at least every three years, making the accreditation question checkable.. That is a claim you can check, not a logo to take on faith.
The dodge sounds like reassurance: "we're fully licensed and accredited," with no specifics, or a badge on the website and irritation when you ask which body issued it. Push for the name of the accreditor and the date of the last review, then confirm it yourself. Some programs, such as opioid treatment programs dispensing methadone, are additionally required by federal regulation to be accredited by an approved body, so the accreditation question has real regulatory weight. A program that cannot or will not point you to verification has shown you something a brochure never would.
How will you decide what level of care I need?
A good program answers this with a process, not a product, because appropriate care is matched to an assessment rather than sold as a fixed package. The ASAM criteria define a standardized continuum of levels of care, from outpatient through medically managed inpatient, matched to a person's assessed severity across several dimensions 2Ref 2American Society of Addiction Medicine (2024).The ASAM Criteria.That ASAM defines a standardized continuum of levels of care matched to assessed severity, so placement should follow an assessment rather than a fixed program offered before one.. The right answer describes an assessment that comes before any recommendation about where and how long you should be treated.
The dodge is a bed or a length of stay quoted before anyone has assessed you: "you'll do our 30-day residential program," offered on the first call. A confident number delivered before an assessment is a product being sold, not a plan being made, and it is a close cousin of the fixed-length model whose famous 28-day figure came from mid-century program design rather than from evidence that it is clinically optimal. If every caller apparently needs the same premium placement, the recommendation is answering a financial question. Asking how the decision gets made, and listening for whether an assessment drives it, exposes that quickly.
Do you offer FDA-approved medications for addiction?
A good program can say plainly which evidence-based medications it offers or supports, because refusing them is a clinical choice with real consequences. For alcohol use disorder, three FDA-approved medications exist, are non-addictive, can be used with or without counseling, and are substantially underused 3Ref 3National Institute on Alcohol Abuse and Alcoholism (2024).Recommend Evidence-Based Treatment: Know the Options.That three FDA-approved medications treat alcohol use disorder, are non-addictive, can be used with or without counseling, and are substantially underused, so refusing medication is a clinical choice worth questioning.. For stimulant use disorder, where no medication is FDA-approved, contingency management is strongly evidence-based and among the most effective treatments available 4Ref 4National Academies of Sciences, Engineering, and Medicine (2023).Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention.That contingency management is strongly evidence-based and among the most effective treatments for stimulant use disorder, for which no medication is FDA-approved.. A program that offers these is aligned with the evidence; one that dismisses them on ideological grounds is not.
The dodge is a program that reframes proven medication as "replacing one drug with another" or insists on an abstinence-only model without acknowledging the alternatives. That is a non-evidence-based red flag, and it is worth asking directly: is this rehab evidence based, and how does it decide when medication is appropriate? A program committed to a single philosophy over the evidence will often reveal it here, because the honest answer to this question exposes a treatment model built on belief rather than on what works.
How do you define and measure success?
A good program gives a careful, qualified answer here, because honest outcome measurement is hard and no reputable program guarantees a result. There is no standard definition of success that facilities are required to report, so a single advertised success rate is unverifiable marketing. Deceptive treatment marketing is not merely distasteful; it is unlawful, and a 2018 federal law gives the Federal Trade Commission authority to act against it, with enforcement that has produced settlements 5Ref 5Federal Trade Commission (2025).Enforcing the Opioid Addiction Recovery Fraud Prevention Act: The FTC's settlement with Evoke Wellness.That deceptive substance-use-treatment marketing is unlawful under a 2018 federal statute giving the FTC enforcement authority, and that enforcement produced a settlement, so advertised success rates deserve skepticism.. A program confident in its care describes what it measures, over what period, and its limits.
The dodge is a confident number: "we have an 80 percent success rate." Ask how success is defined, over what timeframe, and whether anyone outside the program verified it. The answers are usually vague, because the figure was chosen to reassure rather than to inform. The outcome data a good facility can actually show you is modest and specific, not a marketing headline, and treating any glossy success rate claim with skepticism is exactly the reflex a bad program hopes you will not have.
What is the total cost, in writing, and is anyone paid to refer me?
A good program will put the total expected cost in writing and answer plainly whether anyone is paid to bring you in, because both questions are about money and both have honest answers. Ask for an itemized estimate before admission, including what happens if insurance pays less than expected. A trustworthy program treats this as a fair request, not an obstacle, and can tell you your likely out-of-pocket cost.
The referral question is the one bad programs least want asked. Ask directly whether the person recommending the facility has any financial relationship with it. Deceptive lead-generation and paid referral practices are common enough that ad platforms built defenses against them: Google requires addiction-treatment advertisers to be certified before they can advertise, a check of their licensing and regulatory history 6Ref 6Google (2024).Healthcare and medicines — Advertising Policies Help.That Google requires addiction-treatment advertisers to be certified before they can advertise, a check of licensing and regulatory history that exists because paid-referral and deceptive lead-generation practices are common.. A legitimate program has nothing to hide about who profits from your admission, and its willingness to answer is itself reassuring. A program that gets defensive when you ask who gets paid has answered the question by refusing it.
Common questions
Related
Substance use & recovery
The Outcome Data an Honest Program Can ShowSubstance use & recovery
The Questions Worth Asking Before You CommitSubstance use & recovery
The Warning Signs of a Predatory Program
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
If things feel heavy, a person is available anytime — call or text 988.
When a question can wait and care cannot
- —Signs of opioid overdose in someone who has used: slow or stopped breathing, blue or gray lips or fingertips, and being impossible to wake
- —Alcohol or benzodiazepine withdrawal with shaking, a racing heart, confusion, hallucinations, or a seizure, which can be life-threatening
- —A program that grows defensive or evasive when asked about license, cost, medication, or paid referrals
- —Any thoughts of suicide or of not wanting to be alive
If someone may be overdosing or is having a withdrawal seizure, call 911 immediately, and use naloxone if it is on hand. For thoughts of suicide, call or text 988 (the Suicide and Crisis Lifeline), or text HOME to 741741.
This article lists questions that help you evaluate a treatment program. It is not medical advice and cannot assess any specific facility for you. Confirm a program's license and accreditation through official sources, and seek an in-person clinical assessment for care decisions.
References
- 1.The Joint Commission (2024). Behavioral Health Care and Human Services Accreditation Program. The Joint Commission. linkThat accreditation by The Joint Commission means an outside reviewer inspected the facility against national safety and quality standards with on-site reviews at least every three years, making the accreditation question checkable.
- 2.American Society of Addiction Medicine (2024). The ASAM Criteria. American Society of Addiction Medicine (ASAM). link ✓That ASAM defines a standardized continuum of levels of care matched to assessed severity, so placement should follow an assessment rather than a fixed program offered before one.
- 3.National Institute on Alcohol Abuse and Alcoholism (2024). Recommend Evidence-Based Treatment: Know the Options. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. link ✓That three FDA-approved medications treat alcohol use disorder, are non-addictive, can be used with or without counseling, and are substantially underused, so refusing medication is a clinical choice worth questioning.
- 4.National Academies of Sciences, Engineering, and Medicine (2023). Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention. National Academies (NCBI Bookshelf). link ✓That contingency management is strongly evidence-based and among the most effective treatments for stimulant use disorder, for which no medication is FDA-approved.
- 5.Federal Trade Commission (2025). Enforcing the Opioid Addiction Recovery Fraud Prevention Act: The FTC's settlement with Evoke Wellness. Federal Trade Commission (FTC) Business Guidance Blog. link ✓That deceptive substance-use-treatment marketing is unlawful under a 2018 federal statute giving the FTC enforcement authority, and that enforcement produced a settlement, so advertised success rates deserve skepticism.
- 6.Google (2024). Healthcare and medicines — Advertising Policies Help. Google Ads Policy. link ✓That Google requires addiction-treatment advertisers to be certified before they can advertise, a check of licensing and regulatory history that exists because paid-referral and deceptive lead-generation practices are common.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy